CMSC Live: 2025 Annual Meeting Day 3

Host

• Jeffrey Wilken, PhD
  President-Elect, Consortium of Multiple Sclerosis Centers (CMSC); assistant professor of neurology, Georgetown University; director of Research, Neuropsychology Associates of Fairfax; executive director, Washington Neuropsychology Research Group

Guest

• Riley Bove, MD
  Associate Professor of Neurology at the University of California, San Francisco; Neurologist, UCSF Weill Institute for Neurosciences

Segment Breakdown

• 00:00 – Jeffrey Wilken, PhD, welcomes viewers to CMSC Day 3, introduces Riley Bove, MD, and highlights her lecture on women’s health in MS—covering pregnancy, lactation, and menopause—calling attention to the lack of coverage in prior meetings
• 01:00 – Riley Bove, MD, explains how reproductive milestones in women with MS can be managed proactively with guidance and care, emphasizing gender-specific biological considerations and medication planning.
• 03:30 – Discussion shifts to MS treatment during pregnancy. Riley Bove, MD, explains that treatment isn’t necessarily halted now; rather, medication use is personalized to minimize fetal risk and maintain disease control.
• 05:00 - Riley Bove, MD, discusses disparities in guideline adoption, noting that while newer providers are being trained in reproductive health in MS, many community clinicians still operate under outdated practices.
• 07:45 - Riley Bove, MD, revisits the controversial history of HRT, clarifies its benefits for perimenopausal symptoms and bone health, and explains how previous studies misled the medical community.
• 10:30 - Riley Bove, MD, highlights growing concerns in men’s mental health, emotional development, and healthcare access—especially in young men—framing it as a parallel issue to under-addressed women’s health.
• 13:15 - Riley Bove, MD, shares her appreciation for the CMSC's comprehensive and collaborative environment, especially its interdisciplinary approach to MS care.
• 14:00 - Jeffrey Wilken, PhD, thanks Riley Bove, MD, for her insightful lecture and interview, and both express their positive experiences at the meeting.

Click here for more coverage of CMSC 2025.